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(1,8% of all admission) and was increased in Eldoret, Kenya (3,1%)
and Rutowu, Burundi (4,1%) and it correlates with altitude. The
“true” HL is still very rare when patients with travel history to
highland are excluded.
http://dx.doi.org/10.1016/j.ijid.2014.03.769
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M.E. Yeolekar ∗, A. Barua, S. Sukumaran, S. Dhariya
K.J.Somaiya Medical College and Hospital, Mumbai,
India
Background: Malaria, endemic in India, tends to be a major
contributor to morbidity and mortality globally. Of the various
species, Plasmodium Falciparum is associated with serious prog-
nosis,(morbidity and mortality) in a sizeable number of patients.
Chloroquine resistance was an important clinical issue; the cur-
rent issue is that of an apparently changing scenario with rising
number of P.Vivax malaria cases, associated with severity of com-
plications. The observational study is aimed to ﬁnd out whether
there is change in P.Vivax malaria features and how it inﬂuences
management.
Methods & Materials: An observational study conducted at a
teaching hospital in centralmetropolitanMumbai, India during the
monsoon months (June-October 2013).
Febrile patients admitted from the medical outdoor and emer-
gency service form the basis of this study. Patients with moderate
to severe degree fever, with chills, localized and generalized body
ache, varying degrees of weakness/fatigue and malaise/lethargy,
vomiting suspected clinically to be suffering from malaria were
tested - by peripheral smear examination/malaria speciﬁc Anti-
gen. Other investigations included total and differential count,
liver function tests- mainly Serum Bilirubin, Transaminases,
renal function tests (Serum Creatinine). Haemodynamic Instability
(hypotension), thrombocytopenia with manifest bleeding, affected
renal function singly and in combination were the differentiating
criteria towards critical care.
Results: A total of 41 cases (29M, 12 F) of malaria were
diagnosed- 39 were P.vivax and 2 were mixed malaria. As many
as 32 patients were found to be thrombocytopenic (platelet
count <1.5 lakhs), the range being from 12,000 to 1.4 lakhs/cumm.
Seven patients (17%) presented with hypotension and required
ICU monitoring. 14 patients (34%) had deranged liver function
test mostly in the form of transaminitis and 3 cases with renal
insufﬁciency.3 patient presentedwith bleeding. 7 patients required
platelet transfusion (4 units each of Random Donor Platelet trans-
fusion) and 1 patient required platelet transfusion twice. Patients
who tested positive for Dengue Antigen fared poorly. Fluctuating
and decreasing platelet countwithout bleeding contributed to pro-
longation of hospital stay.
Conclusion: P.falciparum has been considered malignant
malaria, P.vivax malaria particularly with thrombocytopenia has
increased in incidence and is not considered benign any longer.
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Deworming HIV-infected pregnant women on
ART demonstrates beneﬁts in low haemoglobin
trajectories
E.I. Ivan
Kigali Health institute,Kigali Rwanda, Kigali, Rwanda
Background: Co- infection with HIV and NTDs is common
in sub Saharan Africa and ﬁndings from previous studies have
suggested that anthelmintic treatment might delay disease pro-
gression in people with HIV. The aim was to determine the effect of
anthelmintic therapy on HIV viral loads, CD4 cell counts and ane-
mia among pregnant women with/without helminth co-infections
among Rwandan women on antiretroviral theraphy.
Methods & Materials: From January 2010 and December 2011,
we enrolled and followed up 1300 subjects, 650 randomised in tar-
geted and 650 in untargeted intervention groups. All subjects were
on ART regimen as part of their PMTCT treatment package. In tar-
geted group we screened all and treated only helminth positive
women. Untargeted group screened and treated all subjects irre-
spective of helminthic infection. CD4 cells counts trajectories and
HIV viral loaddetectionweremeasuredbetweengroups at baseline
to post delivery treatment in a prospective cohort. Haemoglobin
levels, prevalence rates and faecal egg count were also determined
from baseline to post treatment time points among cohort groups
Results: There was a statistically signiﬁcant difference in
change of haemoglobin levels among subjects with Hb<11g/dL
vs. > 11gd/L at post treatment visit in between treatment groups
(p=0.04) and a higher cure rate with reduced intensity for
helminthic infection rates among positives. At visit 4, we found
a marginal treatment effect (p =0.086) in subjects with lower
CD4 counts (<350; >350) among negative untargeted vs. targeted
groups. However, no signiﬁcant difference was found in levels of
viral load detection (p=0.5 vs. 0.6) for all subjects at pre and post
intervention visits. Treatment between targeted and untargeted
groups demonstrated signiﬁcant reduction innumber of egg counts
in both groups implying treatment effectiveness on infection over
time.
Conclusion: Our ﬁndings demonstrated that less costly general
de-worming versus targeted de-worming is not inferior in its ben-
eﬁcial effects of de-worming. Deworming does not, in our setting,
statistically signiﬁcantly delay HIV disease progression in women
withHIVonART, butwithhaemoglobin levels < 11g/dL vs. > 11g/dL
(p<0.05); without signiﬁcant effect irrespective of the deworming
method on CD4 cell count and viral load trajectories
http://dx.doi.org/10.1016/j.ijid.2014.03.771
